Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
2000-9-19
pubmed:abstractText
Vanillyl-alcohol oxidase (VAO) is the prototype of a newly recognized family of structurally related oxidoreductases sharing a conserved FAD-binding domain. The active site of VAO is formed by a cavity where the enzyme is able to catalyze many reactions with phenolic substrates. Among these reactions is the stereospecific hydroxylation of 4-ethylphenol-forming (R)-1-(4'-hydroxyphenyl)ethanol. During this conversion, Asp-170 is probably critical for the hydration of the initially formed p-quinone methide intermediate. By site-directed mutagenesis, the putative active site base has been relocated to the opposite face of the active site cavity. In this way, a change in stereospecificity has been achieved. Like native VAO, the single mutants T457E, D170A, and D170S preferentially converted 4-ethylphenol to the (R)-enantiomer of 1-(4'-hydroxyphenyl)ethanol. The double mutants D170A/T457E and D170S/T457E exhibited an inverted stereospecificity with 4-ethylphenol. Particularly, D170S/T457E was strongly (S)-selective, with an enantiomeric excess of 80%. The crystal structure of D170S/T457E, in complex with trifluoromethylphenol, showed a highly conserved mode of ligand binding and revealed that the distinctive catalytic properties of this mutant are not caused by major structural changes.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-10430865, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-10585424, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-10623531, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-10700149, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-10752605, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-10809721, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-1396672, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-15299374, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-15299554, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-15299723, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-15299926, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-16535508, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-2025413, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-2657660, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-2990444, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-4286147, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-6083780, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-7552726, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-8529652, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-8823175, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-8823176, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-9013853, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-9218444, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-9261083, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-9514256, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-9525880, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-9644973, http://linkedlifedata.com/resource/pubmed/commentcorrection/10920192-9791114
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
97
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9455-60
pubmed:dateRevised
2010-10-13
pubmed:meshHeading
pubmed-meshheading:10920192-Alcohol Oxidoreductases, pubmed-meshheading:10920192-Amino Acid Substitution, pubmed-meshheading:10920192-Aspartic Acid, pubmed-meshheading:10920192-Binding Sites, pubmed-meshheading:10920192-Catalysis, pubmed-meshheading:10920192-Crystallography, X-Ray, pubmed-meshheading:10920192-Glutamic Acid, pubmed-meshheading:10920192-Hydrogen-Ion Concentration, pubmed-meshheading:10920192-Hydroxylation, pubmed-meshheading:10920192-Kinetics, pubmed-meshheading:10920192-Models, Molecular, pubmed-meshheading:10920192-Mutation, pubmed-meshheading:10920192-Penicillium, pubmed-meshheading:10920192-Phenols, pubmed-meshheading:10920192-Phenylethyl Alcohol, pubmed-meshheading:10920192-Protein Conformation, pubmed-meshheading:10920192-Protein Engineering, pubmed-meshheading:10920192-Stereoisomerism, pubmed-meshheading:10920192-Structure-Activity Relationship, pubmed-meshheading:10920192-Substrate Specificity, pubmed-meshheading:10920192-Water
pubmed:year
2000
pubmed:articleTitle
Inversion of stereospecificity of vanillyl-alcohol oxidase.
pubmed:affiliation
Department of Biomolecular Sciences, Laboratory of Biochemistry, Wageningen University, The Netherlands.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't